Literature DB >> 2425561

Interferon treatment of human neoplasia.

H Strander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425561

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  20 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 2.  The potential of interferons in malignant disease.

Authors:  K Okita; T Kaneko
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

3.  Inhibition of wound healing in mice by local interferon alpha/beta injection.

Authors:  A J Stout; I Gresser; W D Thompson
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

Review 4.  Clinical evaluation of treatment with interferon.

Authors:  H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

5.  Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity.

Authors:  S Einhorn; P Ling; N Einhorn; H Strander; J Wasserman
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL).

Authors:  Mehdi Allahbakhshian Farsani; Masomeh Kamel; Mahdieh Mehrpouri; Reza Shiri Heris; Mohsen Hamidpour; Sina Salari; Mohamad Hosien Mohamadi
Journal:  Pathol Oncol Res       Date:  2018-11-15       Impact factor: 3.201

Review 7.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

Review 8.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

Authors:  Y Watanabe; K Kuribayashi; S Miyatake; K Nishihara; E Nakayama; T Taniyama; T Sakata
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 10.  Interferon treatment of human malignancies--a short review.

Authors:  S Einhorn; H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.